In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Jomed's Rising Star

Executive Summary

Over the past three years, Jomed's sales growth has been dramatic, as the company has challenged market leaders like Guidant and AVE in the European stent marketplace. But, unlike other small cardiovascular start-ups, Jomed won't be content with a strong stent business--it is actively engaged in building a broad-based cardiovascular business that is truly global..
Advertisement

Related Content

Volcano's Second Act
Volcano's Second Act
Millimed's Play in Interventional Neurology
The Sorin Group: Europe's Last, Best Hope in Cardiovascular Devices
Millimed models Jomed in interventional neurology
Abbott Moves One Way in Cardiovascular Devices, Another in Orthopedics, To Get To the Same Place
Jomed's Global Positioning
Resurrecting Cordis
Jomed Stakes Out the US
Stent Wars: The Sequel--Is J&J Back?

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV001171

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel